Log in to search using one of your social media accounts:


Construction and recombinant expression of Pseudomonas aeruginosa truncated exotoxin A in Escherichia coli.

Construction and recombinant expression of Pseudomonas aeruginosa truncated exotoxin A in Escherichia coli. Cell Mol Biol (Noisy-le-grand). 2018 Jan 31;64(1):64-69 Authors: Qaiser H, Aslam F, Iftikhar S, Farooq A Abstract Pseudomonas aeruginosa exotoxin A (PE) is a bacterial toxin composed of three domains namely: cell binding, translocation and enzymatic domain. The cytotoxic activity of PE is attributed to the enzymatic domain, which inhibits protein synthesis through ADP-ribosylation of EF-2. PE can be genetically modified to fight cancer. In this regard, a truncated and modified form of PE was produced that could be used for more potent immunotoxins. This modified form termed PE38KDEL was completely devoid of cell binding domain and parts of translocation domain II and Ib which are reported to be inessential for cytotoxicity of the toxin. The resultant expressed protein consisted of the essential translocation domain II and catalytic subunit (domain Ib, III). The deletions in the exotoxin A gene for truncated protein production were made via overlapping PCR extension. The amplicon was cloned in pTZ57r-T vector for DNA works and sub cloned in pET22b expression vector.  It is demonstrated here that PE38KDEL can be expressed in huge quantities in Escherichia coli by using the recombinant vector PE38KDEL/pET under control of T7 promoter and E. coli host strain BL21 (DE3) CodonPlus. The protein expression was optimized at 0.5 mM IPTG concentration for...
Source: Cellular and Molecular Biology - Category: Molecular Biology Tags: Cell Mol Biol (Noisy-le-grand) Source Type: research

Related Links:

The thumbnail take on finasteride has been that it prevents prostate cancer but increases the risk for high-grade disease. A new study debunks the latter idea.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Smart technologies can sift through data to help the NHS spot diseases quicker, the PM is to say.
Source: BBC News | Health | UK Edition - Category: Consumer Health News Source Type: news
LONDON (Reuters) - Prime Minister Theresa May will call on Britain's health service, charities and artificial intelligence sector to work together to better identify patients with the early stages of cancer and stop thousands dying each year.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
This article will discuss those efforts and results to date. PMID: 29766832 [PubMed - as supplied by publisher]
Source: Current Radiopharmaceuticals - Category: Radiology Tags: Curr Radiopharm Source Type: research
This study assessed the survival impact of combined surgery to the primary tumor and metastatic disease in the management of metastatic NSCLC. Stage IV NSCLC patients at presentation, diagnosed from 2004 to 2013 were identified from the SEER (Surveillance, Epidemiology, and End Results) database. Propensity-matched analysis was performed considering baseline characteristics (age, gender, race, histology, TN stage, and site of metastases). A total of 144,334 patients were identified. The median age group was 65-70 years, and 1139 patients (0.8% of the patients) have received surgical treatment to both the primary tumor...
Source: Cancer Investigation - Category: Cancer & Oncology Tags: Cancer Invest Source Type: research
Conclusions: Peroral arsenic has little effect on local airway immune responses to bacteria but compromises respiratory epithelial barrier integrity, increasing systemic translocation of inhaled pathogens and small molecules. https://doi.org/10.1289/EHP1878 Received: 09 March 2017 Revised: 14 August 2017 Accepted: 16 August 2017 Published: 28 September 2017 Address correspondence to M.B. Fessler, National Institute of Environmental Health Sciences, 111 T.W. Alexander Dr., P.O. Box 12233, Maildrop D2-01, Research Triangle Park, NC 27709 USA. Telephone: (919) 541-3701. Email: fesslerm@niehs.nih.gov *Current address: UN...
Source: EHP Research - Category: Environmental Health Authors: Tags: Research Source Type: research
Basic scienceExploring anti-stem cell therapy in colorectal cancer  Storm EE, Durinck S, de Sousa e Melo F, et al. Targeting PTPRK-RSPO3 colon tumours promotes differentiation and loss of stem cell function. Nature 2016;529:97–100. Adenomatous polyposis coli mutations resulting in activation of the WNT pathway are thought to be a founder event in the majority of human colorectal cancers (CRCs), yet targeting the WNT pathway has not yielded any effective therapies. There is a subset of CRCs that express recurrent gene fusions of members of the R-spondin (RSPO, WNT agonists) that exhibit WNT activation through tra...
Source: Gut - Category: Gastroenterology Authors: Tags: JournalScan Source Type: research
ConclusionOur results imply that EGCG may be useful for prevention of intestinal disorders or bacterial infection in animals/humans.This article is protected by copyright. All rights reserved
Source: Nahrung / Food - Category: Nutrition Authors: Tags: Research Article Source Type: research
Conclusions: We did not find consistent associations between presence of subgingival periodontal pathogens and risk of several cancers, but suggestion of associations with early colonizing pathogens for total and lung cancer. These conclusions are restricted by the small numbers of events and of bacteria evaluated. To clarify the present findings, further research is needed utilizing larger cohorts and more comprehensive assessment of presence and quantity of oral bacteria.Citation Format: Xiaodan Mai, Robert J. Genco, Michael J. LaMonte, Kathleen M. Hovey, Jo L. Freudenheim, Christopher A. Andrews, Jean Wactawski-Wende. P...
Source: Cancer Research - Category: Cancer & Oncology Authors: Tags: Epidemiology Source Type: research
Conclusions: CIMP+ CRC are associated with a distinct microbiome including pks containing bacteria (K. pneumoniae and E. coli) and 2HG producing bacteria (Fusobacterium), raising the possibility that the methylation defect could be contributed to by the microbiome.Citation Format: Ang Sun, Matteo Cesaroni, Christian Jobin, Carlos Barrero, Jaroslav Jelinek, Jacqueline D. Sautter, Thomas E. Rams, Salim Merali, Jean-Pierre Issa. Distinct microbiome in colorectal cancers with the CpG Island Methylator Phenotype. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18...
Source: Cancer Research - Category: Cancer & Oncology Authors: Tags: Tumor Biology Source Type: research
More News: Biology | Cancer | Cancer & Oncology | Gastroenteritis | Genetics | Molecular Biology | Translocation